Intermune News
Most Popular Intermune Story
InterMune shares bludgeoned after FDA demands new trial for pirfenidone
InterMune took its best case for pirfenidone to the FDA, and lost. The agency ruled Tuesday afternoon that the developer would need to mount a new clinical trial for the drug before it could provide Read more...
Latest Headlines
- August 15, 2011
- April 28, 2011
- April 15, 2011
- January 10, 2011
- December 17, 2010
- October 7, 2010
- April 14, 2010
- March 9, 2010
- March 8, 2010
- March 5, 2010
- February 3, 2009
- November 26, 2007
- March 19, 2007
- March 5, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
